Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 70,524 |
|
|||||
| News | - | ||||||
| Day High | 28.93 | Low High |
|||||
| Day Low | 24.26 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cartesian Therapeutics Inc | RNAC | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.015 | 0.06% | 25.475 | 16:02:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 25.84 | 24.26 | 28.93 | 25.475 | 25.46 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,566 | 70,524 | $ 26.22 | $ 1,849,154 | - | 11.665 - 42.60 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:07:30 | 8 | $ 25.46 | USD |
Cartesian Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.12B | 161.95M | - | 26M | -219.71M | -1.36 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cartesian Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RNAC Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 26.84 | 29.19 | 23.51 | 25.33 | 76,629 | -1.37 | -5.09% |
| 1 Month | 20.37 | 29.19 | 20.01 | 23.81 | 91,020 | 5.11 | 25.06% |
| 3 Months | 21.948 | 29.19 | 11.665 | 18.88 | 428,784 | 3.53 | 16.07% |
| 6 Months | 39.60 | 42.60 | 11.665 | 22.42 | 615,087 | -14.13 | -35.67% |
| 1 Year | 24.195 | 42.60 | 11.665 | 23.43 | 650,871 | 1.28 | 5.29% |
| 3 Years | 24.195 | 42.60 | 11.665 | 23.43 | 650,871 | 1.28 | 5.29% |
| 5 Years | 24.195 | 42.60 | 11.665 | 23.43 | 650,871 | 1.28 | 5.29% |
Cartesian Therapeutics Description
| Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL-313 for Ornithine Transcarbamylase Deficiency (OTC), and others. |
